Neoplasma
Overview
Neoplasma is a peer-reviewed scientific journal dedicated to the study of cancer research and related fields. It publishes original articles, reviews, and case reports, covering various aspects of neoplastic diseases, including etiology, pathogenesis, diagnosis, treatment, and prevention. With a focus on advancing knowledge in oncology, Neoplasma serves as a valuable resource for researchers, clinicians, and healthcare professionals striving to improve cancer management and patient outcomes.
Details
Details
Metrics
Metrics
h-index / Ranks: 6461
57
SJR / Ranks: 7654
588
CiteScore / Ranks: 5069
5.00
JIF / Ranks: 3481
3.0
Recent Articles
1.
Fan H, Ding Y, Xiao Z, Li S, Zheng Y
Neoplasma
. 2025 Jan;
71(6):559-570.
PMID: 39832206
Many lines of evidence suggest that circular RNAs (circRNAs) are closely associated with the occurrence and progression of colon cancer. The objective of this study was to investigate the regulatory...
2.
Lin J, Zhu Q, Zeng F
Neoplasma
. 2025 Jan;
71(6):581-593.
PMID: 39832205
Esophageal squamous cell carcinoma (ESCC) has high mortality. The role and regulatory mechanism of hsa_circ_0021727 (circ_0021727) in ESCC remain largely unknown. This study focused on the undiscovered impact of circ_0021727...
3.
Rosova B, Filipova A, Hadzi Nikolov D, Drosslerova M, Matej R, Rozsypalova A, et al.
Neoplasma
. 2025 Jan;
71(6):594-602.
PMID: 39832204
The objective of this study was to investigate the prognostic significance of the frequency of primary cilia (PC) and β-catenin expression in 218 patients (pts) with non-small cell lung cancer...
4.
Put A, Smesny Trtkova K, Skarda J
Neoplasma
. 2025 Jan;
71(6):511-532.
PMID: 39832203
DNA methylation is recognized as an early event in cancer initiation and progression. This review aimed to compare the methylation status of promoter regions in selected genes across different histological...
5.
Zhang Q, Mao J, Xie L, Lu Y, Li X, Yu X, et al.
Neoplasma
. 2025 Jan;
71(6):544-558.
PMID: 39832202
MTHFD2 is highly overexpressed in breast cancer tissues, indicating that it might be used as a target in breast cancer treatment. This study aims to determine the role of MTHFD2...
6.
Shi C, Wang X, Li J, Wu S, Liu Z, Ren X, et al.
Neoplasma
. 2025 Jan;
71(6):533-543.
PMID: 39832201
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast malignancy. Although some patients benefit from immune checkpoint therapy, current treatment methods rely mainly on chemotherapy. It is imperative...
7.
Chen J, Zheng W, Li Q, Xu R, Bai T, Pan C
Neoplasma
. 2025 Jan;
71(6):571-580.
PMID: 39832200
Regarding flotillin knockdown, drug resistance is reversed in colorectal cancer (CRC) cell lines; this is associated with the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway, as our previous experimental results indicated....
8.
Bublakova E, Makohusova M, Ballova A, Husakova K, Hederova S, Mocna A, et al.
Neoplasma
. 2025 Jan;
71(6):603-609.
PMID: 39832199
Pediatric central nervous system (CNS) tumors represent 20-25% of childhood malignancies, with 35-40 new cases annually in Slovakia. Despite treatment advances, high mortality and poor quality of life in a...
9.
Ying X, Shi Z, Shao R, You G, Song Z
Neoplasma
. 2024 Nov;
71(5):509.
PMID: 39556434
Due to the delayed delivery of the request for a correction and the requirement from the Office of Zhejiang Chinese Medical University to standardize the institution's English translation, the editorial...
10.
Guo D, Ma C, Gu J, Zhai X, Chen X, Ju G, et al.
Neoplasma
. 2024 Nov;
71(5):442-450.
PMID: 39556433
Prostate cancer (PCa) is the most frequently diagnosed malignant tumor in males, and there are currently few effective therapeutic targets following hormone therapy resistance. Subunits of eukaryotic initiation factor 3...